Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 78.65
+0.95 (1.22%)
Aug 7, 2026, 2:29 PM CET
Pharma Mar Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 393.38 | 221.39 | 349.96 | 158.15 | 359.47 | 229.83 |
Revenue Growth | -3.34% | -36.74% | 121.28% | -56.00% | 56.41% | -14.87% |
Gross Profit Gross Profit Growth | 209.13 | 209.13 | 338.97 | 148.54 | 347.26 | 213.39 |
Operating Income Operating Income Growth | 60.72 | 60.72 | 21.97 | -3.83 | 61.88 | 92.45 |
Net Income Net Income Growth | 74.99 | 74.99 | 40.23 | 1.14 | 58.95 | 92.86 |
Earnings Per Share EPS Growth | 4.30 | 4.30 | 1.49 | 0.06 | 2.73 | 5.13 |
EPS Growth | 188.59% | 188.59% | 2383.33% | -97.80% | -46.78% | -31.51% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Oncology Oncology Growth | 221.35 | 174.59 | 156.84 | 191.18 | 224.67 |
RNA Interference (RNAi) RNA Interference (RNAi) Growth | 0.04 | 0.26 | 0.12 | 0.03 | 0 |
Total Total Growth | 221.39 | 174.86 | 158.15 | 196.34 | 229.83 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 167.22 | 167.22 | 154.53 | 162.56 | 176.17 | 201.88 |
Total Debt Total Debt Growth | 49.42 | 49.42 | 51.08 | 43.67 | 33.82 | 49.33 |
Net Cash (Debt) Net Cash Growth | 117.81 | 117.81 | 103.45 | 118.89 | 142.35 | 152.55 |
Net Cash Growth | 13.88% | 13.88% | -12.99% | -16.48% | -6.68% | 9.86% |
Net Cash Per Share Net Cash Per Share Growth | 6.75 | 6.75 | 5.89 | 6.64 | 7.88 | 8.44 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 53.13 | 53.13 | 6.03 | -6.6 | 38.32 | 38.19 |
Capital Expenditures CapEx Growth | -8.39 | -6.46 | -15.02 | -3.5 | -8.85 | -6.27 |
Free Cash Flow Free Cash Flow Growth | 44.74 | 46.67 | -8.99 | -10.1 | 29.47 | 31.92 |
Free Cash Flow Growth | - | - | - | - | -7.68% | -88.43% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.16% | 94.46% | 96.86% | 93.92% | 96.60% | 92.85% |
Operating Margin | 15.43% | 27.42% | 6.28% | -2.42% | 17.22% | 40.22% |
Pretax Margin | 15.16% | 26.94% | 6.74% | -2.29% | 16.18% | 41.39% |
Profit Margin | 19.06% | 33.87% | 11.49% | 0.72% | 16.40% | 40.40% |
FCF Margin | 11.37% | 21.08% | -2.57% | -6.38% | 8.20% | 13.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 0.800 | 0.650 | 0.650 | 0.650 |
Dividend Per Share Growth | 25.00% | 25.00% | 23.08% | 0% | 0% | 8.33% |
Dividend Yield | 1.29% | 1.07% | 0.82% | 1.59% | 1.01% | 1.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.97 | 17.42 | 53.56 | 684.67 | 23.55 | 11.12 |
Forward PE | 18.18 | 24.03 | 36.29 | 67.76 | 16.74 | 12.76 |
P/FCF Ratio | 24.94 | 27.82 | - | - | 39.51 | 32.17 |
PS Ratio | 6.16 | 5.86 | 4.00 | 4.58 | 3.24 | 4.47 |